Nautilus Biotechnology, Inc. Research And Development Expense

Quick Answer

Nautilus Biotechnology, Inc. reported Research And Development Expense of $41.11 million for the year ending 2025.

  • Nautilus Biotechnology, Inc. showed a decrease of -18.6% in Research And Development Expense from 2024 to 2025.
  • This data is from Nautilus Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Nautilus Biotechnology, Inc.'s Research And Development Expense has grown by 230.7%.
  • Historical annual values: Fiscal year 2025: $41.11 million | Fiscal year 2024: $50.48 million | Fiscal year 2023: $47.25 million | Fiscal year 2022: $37.67 million | Fiscal year 2021: $29.35 million | Fiscal year 2020: $12.43 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: